STRESS-PROTECTIVE EFFICACY OF PERSEN ® FORTE
- Authors: Vorobyeva O.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 23, No 3 (2012)
- Pages: 26
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115321
- ID: 115321
Cite item
Open Access
Access granted
Abstract
The paper presents the results ofa large-scale open-label trial to evaluate the efficacy and safety of Persen® forte in arresting the conditions associated with acute and chronic psychosocial stress in 50 650 health care facility outpatients followed-up by 6300 physicians (neurologists and therapists). After two-week Persen® forte therapy, a considerable improvement was reported by 87 and 63% ofpatients with symptoms ofchronic andacute stress, respectively. Persen® forte was excellently and well tolerated by 87 and 89% of male and female respondents, respectively.
Full Text
About the authors
O. Vorobyeva
I.M. Sechenov First Moscow State Medical University
Email: ovvorobeva@mail.ru
References
- Воробьева O. В., Рябоконь И. В. Открытое наблюдательное исследование стрессопротективной эффективности препарата Персен // РМЖ., - 2011; 19 (15): 979-984.
- Donath F., Quispe S., Diefenbach K. et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality // Pharmacopsychiatry. - 2000; 33: 47-53.
- Ortiz J., Nieves-Natal J., Chavez P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release // Neurochem Res. - 1999; 24: 1373-1378.
- Santos M., Ferreira F., Cunha A. et al. Synaptosomal GABA release as influenced by valerian root extract- involvement of the GABA carrier // Arch. Int. Pharmacodyn. - 1994; 327: 220-231.
- Schulz H., Stolz C., Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study // Pharmacopsychiatry. - 1994; 27: 147-151.
- Schumacher B., Scholle S., Holzl J. et al. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A1 adenosine receptors. // J. Nat. Prod. - 2002; 65: 1479-1485.
Supplementary files
